Rome consensus conference - statement; human papilloma virus diseases in males

Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males

(2011) Anna R. Giuliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Papillomavirus humain (HPV) : comment ai-je attrapé ça ?

(2010) N. Gavillon et al.   GYNECOLOGIE OBSTETRIQUE & FERTILITE

Human papilloma virus in the sperm cryobank: an emerging problem?

(2010) C. Foresta et al.   INTERNATIONAL JOURNAL OF ANDROLOGY

Prevalence of human papillomavirus infection in the urinary tract of men with urethritis

(2010) Kazuyoshi Shigehara et al.   INTERNATIONAL JOURNAL OF UROLOGY

Human Papillomavirus-Related Disease in Men: Not Just a Women's Issue

(2010) Joel M. Palefsky   JOURNAL OF ADOLESCENT HEALTH

Prevalence of and Risk Factors for Anal Human Papillomavirus Infection in Men Who Have Sex with Women: A Cross‐National Study

(2010) Alan G. Nyitray et al.   JOURNAL OF INFECTIOUS DISEASES

Distribution of human papillomavirus types in the anogenital tract of females and males

(2010) Luisa Barzon et al.   JOURNAL OF MEDICAL VIROLOGY

Human papillomavirus (HPV) prevalence and type distribution, and HPV-associated cytological abnormalities in anal specimens from men infected with HIV who have sex with men

(2010) Audrey Damay et al.   JOURNAL OF MEDICAL VIROLOGY

A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

(2009) S. K. Kjaer et al.   Cancer Prevention Research

Human Papillomavirus Infections Among Couples in New Sexual Relationships

(2009) Ann N. Burchell et al.   EPIDEMIOLOGY

Prevalence and risk factors of human papillomavirus infection by penile site in uncircumcised Kenyan men

(2009) Jennifer S. Smith et al.   INTERNATIONAL JOURNAL OF CANCER

Association of Oncogenic and Nononcogenic Human Papillomavirus With HIV Incidence

(2009) Bertran Auvert et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial

(2009) Nubia Muñoz et al.   LANCET

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

(2009) J Paavonen et al.   LANCET

Epidemiology of Mucosal Human Papillomavirus Infection and Associated Diseases

(2009) Helen Trottier et al.   Public Health Genomics

Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women

(2009) C K Fairley et al.   SEXUALLY TRANSMITTED INFECTIONS

Human papillomavirus genotypes and phylogenetic analysis of HPV-16 variants in HIV-1 infected subjects in Italy

(2009) Elisabetta Tanzi et al.   VACCINE

The Human Papillomavirus Infection in Men Study: Human Papillomavirus Prevalence and Type Distribution among Men Residing in Brazil, Mexico, and the United States

(2008) A. R. Giuliano et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

HPV prevalence among healthy Italian male sexual partners of women with cervical HPV infection

(2008) Maria Benevolo et al.   JOURNAL OF MEDICAL VIROLOGY

Self-collection of genital human papillomavirus specimens in heterosexual men

(2008) G S Ogilvie et al.   SEXUALLY TRANSMITTED INFECTIONS

Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention

(2008) Luisa Barzon et al.   Infectious Agents and Cancer

The role of high-risk HPV-DNA testing in the male sexual partners of women with HPV-induced lesions

(2007) Paulo C. Giraldo et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology